TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2952868

Group type: EXPERIMENTAL
Intervention: Prophylactic drainage of abdominal wounds with a closed suction system
Number of subjects: 0

Group type: COMPARATOR
Intervention: No drainage (control group)
Number of subjects: 0
Study: 29294081

Group type: EXPERIMENTAL
Intervention: Best Possible Self intervention
Number of subjects: 71

Group type: COMPARATOR
Intervention: Daily Activities control condition
Number of subjects: 71
Study: 27342586

Group type: EXPERIMENTAL
Intervention: Young subjects with visual impairment (age ≤40 years)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Elderly subjects with visual impairment (age >40 years)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Subjects without visual impairment (both age groups)
Number of subjects: 324
Study: 25437697

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Magnesium sulphate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 60
Study: 23426037

Group type: EXPERIMENTAL
Intervention: Green tea catechins (GTCs) with or without caffeine
Number of subjects: 1584

Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 1584
Study: 20844475

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 18261537

Group type: EXPERIMENTAL
Intervention: Enalapril (E) 10 mg/d
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Losartan (L) 50 mg/d
Number of subjects: 76

Group type: COMPARATOR
Intervention: Enalapril + Losartan (E(+)L(+): 10 mg/d + 50 mg/d)
Number of subjects: 76

Group type: COMPARATOR
Intervention: No medication (E(−):L(−))
Number of subjects: 76
Study: 15842584

Group type: EXPERIMENTAL
Intervention: Lamivudine treatment
Number of subjects: 82

Group type: COMPARATOR
Intervention: Patients with YMDD mutations
Number of subjects: 82
Study: 14608128

Group type: EXPERIMENTAL
Intervention: Bivalirudin high-dose group (1 mg/kg bolus; 2.5 mg/kg/hour infusion for 4 hours)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Bivalirudin low-dose group (0.75 mg/kg bolus; 1.75 mg/kg/hour infusion)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Bivalirudin (both high and low dose)
Number of subjects: 52
Study: 10838464

Group type: EXPERIMENTAL
Intervention: CF supplementation (1 mg beta-carotene/kg body weight/day for 12 weeks, then 10 mg beta-carotene/day for the next 12 weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: CF placebo
Number of subjects: 24
Study: 9088815

Group type: EXPERIMENTAL
Intervention: Single injection technique (45 mL of mepivacaine 1% with adrenaline 5 micrograms mL‐1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Multiple injections technique (45 mL of mepivacaine 1% with adrenaline 5 micrograms mL‐1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Single injection technique (after supplementation)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Multiple injections technique (after supplementation)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Both techniques
Number of subjects: 80
Study: 8462363

Group type: EXPERIMENTAL
Intervention: High-dose octreotide (N = 9)
Number of subjects: 19
Study: 3770281

Group type: EXPERIMENTAL
Intervention: Buphenine hydrochloride
Number of subjects: 170

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170
Study: 29644874

Group type: EXPERIMENTAL
Intervention: Device-prohibited (intervention)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Device-allowed (control)
Number of subjects: 112
Study: 26911132

Group type: EXPERIMENTAL
Intervention: hsCRP reduction in patients receiving AVR
Number of subjects: 1423

Group type: EXPERIMENTAL
Intervention: hsCRP reduction in patients not receiving AVR
Number of subjects: 1423

Group type: EXPERIMENTAL
Intervention: hsCRP1 as a predictor for AVR
Number of subjects: 1423

Group type: EXPERIMENTAL
Intervention: hsCRP0 as a predictor for AVR
Number of subjects: 1423

Group type: EXPERIMENTAL
Intervention: AVR rates based on hsCRP changes
Number of subjects: 1423

Group type: EXPERIMENTAL
Intervention: AVR rates in patients with reduced hsCRP
Number of subjects: 1423
Study: 24611923

Group type: EXPERIMENTAL
Intervention: Counselor-Assisted Problem Solving (CAPS)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Information-based Internet Resource Comparison (IRC)
Number of subjects: 132
Study: 21678169

Group type: EXPERIMENTAL
Intervention: Implementation intentions (II)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Combination of implementation intentions and self-efficacy (II + SE)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Self-efficacy (SE)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Control group (written information on nutrition)
Number of subjects: 163
Study: 20147968

Group type: EXPERIMENTAL
Intervention: 150 ml of fermented milk (FM)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: 300 ml of fermented milk (FM)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo (chemically acidified milk)
Number of subjects: 94
Study: 18400556

Group type: EXPERIMENTAL
Intervention: Continuous theta burst stimulation (cTBS)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (iTBS)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Conventional rTMS paradigms
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Asymmetric monophasic pulse with posteriorly directed current flow
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Half-sine pulse with postero-anterior current
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Biphasic stimuli
Number of subjects: 9
Study: 15842266

Group type: EXPERIMENTAL
Intervention: 0.2% PHMB mouthrinse (A)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 0.12% aqueous chlorhexidine solution (B)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 0.3% triclosan/2.0% copolymer mouthrinse (C)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo rinse (10% ethanol, flavour) (D)
Number of subjects: 16
Study: 12458403

Group type: EXPERIMENTAL
Intervention: Cold Pressor Test (CPT)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Response to Cold Pressor Test (CPT)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: CPT- group
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 46
Study: 9666765

Group type: EXPERIMENTAL
Intervention: Single-dose antibiotic prophylaxis with 1 g of ceftriaxone intravenously 1-2 hours before surgery
Number of subjects: 127

Group type: COMPARATOR
Intervention: No antibiotic prophylaxis
Number of subjects: 127
Study: 7634503

Group type: EXPERIMENTAL
Intervention: High dose r‐hGH (40 IU/m2/week)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Standard dose r‐hGH (20 IU/m2/week)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: r‐hGH therapy
Number of subjects: 29
Study: 3398652

Group type: EXPERIMENTAL
Intervention: Cefazolin and metronidazole (group A)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Cefazolin alone (group B)
Number of subjects: 330
Study: 31362034

Group type: EXPERIMENTAL
Intervention: Bi-anodal tDCS (2 mA, twice-daily sessions for five consecutive days)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bi-anodal tDCS
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 60
Study: 29608039

Group type: EXPERIMENTAL
Intervention: 0.025% HOCl
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.05% HOCl
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.12% CHX
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.2% CHX
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: HOCl
Number of subjects: 75
Study: 26156961

Group type: EXPERIMENTAL
Intervention: WM training with a rehearsal strategy
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: WM training without strategy instruction
Number of subjects: 58

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 58
Study: 25791116

Group type: EXPERIMENTAL
Intervention: Live attenuated recombinant tetravalent dengue vaccine candidate (TDV), given in 2 doses 90 days apart
Number of subjects: 72
Study: 23583618

Group type: EXPERIMENTAL
Intervention: VR simulator warm-up (3-5 minutes)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Leisure book reading (10 minutes)
Number of subjects: 51
Study: 20971463

Group type: EXPERIMENTAL
Intervention: Modified ICSI technique using zona pellucida (ZP)-bound sperm; n = 53 couples
Number of subjects: 106

Group type: COMPARATOR
Intervention: Conventional intracytoplasmic sperm injection (ICSI); n = 53 couples
Number of subjects: 106
Study: 19930363

Group type: EXPERIMENTAL
Intervention: Clinical Supervision implementation
Number of subjects: 0
Study: 16723319

Group type: EXPERIMENTAL
Intervention: Unmedicated schizophrenia patients
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Medicated schizophrenia patients
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Acutely psychotic schizophrenia patients (medicated and unmedicated)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Partial remission schizophrenia patients (medicated)
Number of subjects: 100
Study: 15640943

Group type: EXPERIMENTAL
Intervention: Epoetin alpha
Number of subjects: 134
Study: 11355749

Group type: EXPERIMENTAL
Intervention: rhGH (0.025 mg/kg BW/day)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: rhIGF-I (0.015 mg/kg BW/day)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: rhGH + rhIGF-I
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 27
Study: 9383694

Group type: COMPARATOR
Intervention: Cervical hip fracture group (n=42)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Trochanteric hip fracture group (n=24)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Cervical hip fracture prediction
Number of subjects: 233
Study: 7955256

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 748

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 748

Group type: COMPARATOR
Intervention: No anticoagulation or antiplatelet therapy
Number of subjects: 748

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 748
Study: 4012240

Group type: EXPERIMENTAL
Intervention: Ampicillin 8 g plus cloxacillin 4 g daily for three days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cephalothin 8 g daily for three days
Number of subjects: 100
Study: 28913630

Group type: EXPERIMENTAL
Intervention: Sleep Position Trainer (SPT)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Oral Appliance Therapy (OAT)
Number of subjects: 99
Study: 26810242

Group type: EXPERIMENTAL
Intervention: Polyhexanide (PLX)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline + Povidone Iodine (PY)
Number of subjects: 100
Study: 25131484

Group type: EXPERIMENTAL
Intervention: IUPU technique group (n = 193)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Routine manipulation group (n = 185)
Number of subjects: 378
Study: 22157392

Group type: EXPERIMENTAL
Intervention: Azithromycin ophthalmic solution 1% administered bid on days 1 and 2 and on days 3 to 29±1
Number of subjects: 50

Group type: COMPARATOR
Intervention: Visine for Contacts rewetting drops administered qid on days 1 to 29±1
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Azithromycin ophthalmic solution 1%
Number of subjects: 50
Study: 20502065

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (untreated patients)
Number of subjects: 0
Study: 18239749

Group type: EXPERIMENTAL
Intervention: Low dose oral corticosteroids
Number of subjects: 0
Study: 17584705

Group type: EXPERIMENTAL
Intervention: Nitroglycerine sublingual application
Number of subjects: 11
Study: 15523717

Group type: EXPERIMENTAL
Intervention: SH U 555 C at 5 micromol Fe/kg b.w.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SH U 555 C at 10 micromol Fe/kg b.w.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SH U 555 C at 20 micromol Fe/kg b.w.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SH U 555 C at 40 micromol Fe/kg b.w.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 16
Study: 11175372

Group type: EXPERIMENTAL
Intervention: Intrathecal administration of 4-aminopyridine at 5 microg/h for 4-5 hours
Number of subjects: 6
Study: 9122864

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine (0.25%)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal saline solution (control group)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine combined with morphine
Number of subjects: 20
Study: 1552460

Group type: EXPERIMENTAL
Intervention: 2-phase oil:water mouthrinse (TPM)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine mouthrinse
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 60
Study: 3995960

Group type: EXPERIMENTAL
Intervention: 100 micrograms sulprostone gel
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 50 micrograms sulprostone gel
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 25 micrograms sulprostone gel
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cervical priming with sulprostone gel
Number of subjects: 60
Study: 31063507

Group type: EXPERIMENTAL
Intervention: Technology-mediated low-intensity behavioural weight loss maintenance (WLM) programme
Number of subjects: 288

Group type: COMPARATOR
Intervention: Standard lifestyle advice via newsletter (control arm)
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Technology-mediated low-intensity behavioural WLM programme
Number of subjects: 288
Study: 28602825

Group type: EXPERIMENTAL
Intervention: Bone Level Implants (OsseoSpeed TX, Astra tech)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Tissue Level Implants (RN SLActive®, Straumann)
Number of subjects: 32
Study: 25804580

Group type: EXPERIMENTAL
Intervention: Accelerated CXL (18 mW/cm², 5 minutes)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard CXL (3 mW/cm², 30 minutes)
Number of subjects: 31
Study: 23469170

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control object
Number of subjects: 54
Study: 21878431

Group type: EXPERIMENTAL
Intervention: IABC plus PCI
Number of subjects: 337

Group type: COMPARATOR
Intervention: PCI alone
Number of subjects: 337
Study: 18848869

Group type: EXPERIMENTAL
Intervention: Vonau flash (Biolab Sanus Farmacêutica, Brazil)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Zofran (GlaxoSmithKline, Brazil)
Number of subjects: 23
Study: 16809569

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cognitive performance and electroencephalogram
Number of subjects: 15
Study: 12770654

Group type: EXPERIMENTAL
Intervention: Group 1 and Group 2 (children weighing less than 20 kg)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Group 1
Number of subjects: 38
Study: 10697373

Group type: EXPERIMENTAL
Intervention: Aspirin (250 mg/day)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Tiklid (500 mg/day)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Tiklid (500 mg/day) + Aspirin (250 mg/day)
Number of subjects: 28
Study: 9351684

Group type: EXPERIMENTAL
Intervention: 1 min 30 s test
Number of subjects: 9

Group type: COMPARATOR
Intervention: 4 min test
Number of subjects: 9
Study: 8222740

Group type: EXPERIMENTAL
Intervention: Corn oil (6 g/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fish oil preparation enriched with omega-3-PUFA (6 g/day, 2.0 g/day of omega-3-PUFA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Corn oil and Fish oil preparation
Number of subjects: 40
Study: 3896432

Group type: EXPERIMENTAL
Intervention: Epidural morphine, 5 mg in 10 ml 0.9% NaCl
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo, 10 ml 0.9% NaCl
Number of subjects: 207
Study: 29617180

Group type: EXPERIMENTAL
Intervention: Trunk muscle training (TMT) and neuromuscular electrical stimulation (NMES)
Number of subjects: 1
Study: 30412147

Group type: EXPERIMENTAL
Intervention: Add-back hormone replacement therapy with mineral waters (MW) and radon therapy (RT) combined with triptorelin in the main group (MG)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Triptorelin treatment in the control group (CG)
Number of subjects: 89
Study: 26891754

Group type: COMPARATOR
Intervention: FiO2 28%
Number of subjects: 31

Group type: COMPARATOR
Intervention: FiO2 40%
Number of subjects: 31
Study: 25473176

Group type: EXPERIMENTAL
Intervention: Low fermentable, oligosaccharides, disaccharides, monosaccharides and polyols diet (LFD)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Normal Danish/Western diet (ND)
Number of subjects: 123
Study: 22522851

Group type: EXPERIMENTAL
Intervention: Oral Vitamin K 1.25mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 20642916

Group type: EXPERIMENTAL
Intervention: Extracorporeal membrane oxygenation (ECMO)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Conventional management (CM)
Number of subjects: 180
Study: 19063836

Group type: EXPERIMENTAL
Intervention: Andrographolide drop-pill (1.5 g, three times a day for 3 days)
Number of subjects: 478

Group type: COMPARATOR
Intervention: Andrographolide tablet (1.5 g, three times a day for 3 days)
Number of subjects: 478
Study: 15676038

Group type: EXPERIMENTAL
Intervention: Giona Easyhaler 200 microg/dose
Number of subjects: 33

Group type: COMPARATOR
Intervention: Pulmicort Turbuhaler 200 microg/dose
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Charcoal administration (40 g)
Number of subjects: 33
Study: 12507361

Group type: EXPERIMENTAL
Intervention: Sad mood induction
Number of subjects: 197

Group type: COMPARATOR
Intervention: Neutral mood induction
Number of subjects: 197
Study: 9641332

Group type: EXPERIMENTAL
Intervention: GIA stapler and buttressed with bovine pericardial sleeves
Number of subjects: 30

Group type: COMPARATOR
Intervention: TA 55 staplers alone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cautery, clamps and silk ties
Number of subjects: 30
Study: 8587086

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (NSAID) for 18 months
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo for 18 months
Number of subjects: 45
Study: 2802959

Group type: EXPERIMENTAL
Intervention: Bilateral constant resistance computerized exercise equipment (concentric contractions)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Bilateral variable resistance exercise equipment (concentric and eccentric contractions)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Nonexercise control group
Number of subjects: 46
Study: 1254792

Group type: EXPERIMENTAL
Intervention: Signal plus noise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noise alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Defined observation intervals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-defined observation intervals
Number of subjects: 0
Study: 31225645

Group type: EXPERIMENTAL
Intervention: Individual face-to-face intervention focusing on protective factors
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 160
Study: 28954920

Group type: EXPERIMENTAL
Intervention: Baseline TQoL (transformed Quality of Life)
Number of subjects: 33357

Group type: COMPARATOR
Intervention: Lowest baseline TQoL quartile
Number of subjects: 33357

Group type: EXPERIMENTAL
Intervention: Poststroke TQoL change
Number of subjects: 33357

Group type: EXPERIMENTAL
Intervention: Baseline TQoL
Number of subjects: 33357
Study: 25940030

Group type: EXPERIMENTAL
Intervention: Rolapitant 180 mg
Number of subjects: 454
Study: 24363523

Group type: EXPERIMENTAL
Intervention: Roux gastrojejunostomy
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional gastrojejunostomy
Number of subjects: 41
Study: 21952611

Group type: EXPERIMENTAL
Intervention: Mosapride citrate
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Nutrient drinking test
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Gastric barostat study
Number of subjects: 28
Study: 19420393

Group type: EXPERIMENTAL
Intervention: Saude na Boa intervention (environmental/organizational changes, physical activity education, personnel training and engagement)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Saude na Boa intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 16958688

Group type: EXPERIMENTAL
Intervention: Early loading protocol (Group A) - overdenture connected 1 week after surgery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional loading protocol (Group B) - overdenture connected after 12 weeks of healing
Number of subjects: 20
Study: 15149513

Group type: EXPERIMENTAL
Intervention: Lipid microspheres loaded with 0.025% clobetasol propionate (formulation A)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Lipophilic ointment in a hydrophilic phase 0.025% (formulation B)
Number of subjects: 45
Study: 11052430

Group type: EXPERIMENTAL
Intervention: Protective mechanical ventilation (PV; respiratory rate, 16 breaths/min; tidal volume, 6 mL/kg; FIO2, 1.0; PEEP, +5)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (CV; respiratory rate, 8 breaths/min; tidal volume, 12 mL/kg; FIO2, 1.0; PEEP, +5)
Number of subjects: 25
Study: 9771950

Group type: EXPERIMENTAL
Intervention: Doxorubicin (30 mg) plus Verapamil (15 mg)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Doxorubicin (30 mg) alone
Number of subjects: 157
Study: 8155011

Group type: EXPERIMENTAL
Intervention: Lazabemide 100 mg/d
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Lazabemide 200 mg/d
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Lazabemide 400 mg/d
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study: 3042215

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional insulin therapy (CIT)
Number of subjects: 18
Study: 31203197

Group type: EXPERIMENTAL
Intervention: Pseudomonas aeruginosa eradication therapy
Number of subjects: 0